AU7075200C1 - Dosages for treatment with anti-ErbB2 antibodies - Google Patents
Dosages for treatment with anti-ErbB2 antibodiesInfo
- Publication number
- AU7075200C1 AU7075200C1 AU70752/00A AU7075200A AU7075200C1 AU 7075200 C1 AU7075200 C1 AU 7075200C1 AU 70752/00 A AU70752/00 A AU 70752/00A AU 7075200 A AU7075200 A AU 7075200A AU 7075200 C1 AU7075200 C1 AU 7075200C1
- Authority
- AU
- Australia
- Prior art keywords
- dosages
- treatment
- erbb2 antibodies
- erbb2
- antibodies
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 102000004965 antibodies Human genes 0.000 title 1
- 108090001123 antibodies Proteins 0.000 title 1
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2006200146A AU2006200146B2 (en) | 1999-08-27 | 2006-01-13 | Dosages for treatment with anti-ErbB2 antibodies |
AU2009201871A AU2009201871A1 (en) | 1999-08-27 | 2009-05-12 | Dosages for treatment with anti-ERBB2 antibodies |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15101899P | 1999-08-27 | 1999-08-27 | |
US60/151018 | 1999-08-27 | ||
US21382200P | 2000-06-23 | 2000-06-23 | |
US60/213822 | 2000-06-23 | ||
PCT/US2000/023391 WO2001015730A1 (en) | 1999-08-27 | 2000-08-25 | DOSAGES FOR TREATMENT WITH ANTI-ErbB2 ANTIBODIES |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2006200146A Division AU2006200146B2 (en) | 1999-08-27 | 2006-01-13 | Dosages for treatment with anti-ErbB2 antibodies |
Publications (3)
Publication Number | Publication Date |
---|---|
AU7075200A AU7075200A (en) | 2001-03-26 |
AU783625B2 AU783625B2 (en) | 2005-11-17 |
AU7075200C1 true AU7075200C1 (en) | 2018-06-21 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1037926T3 (en) | TREATMENT WITH ANTI-ErbB2 ANTIBODIES | |
AU1290001A (en) | Antibodies | |
ZA200110263B (en) | Humanized anti-ERBB2 antibodies and treatment with anti-ERBB2 antibodies. | |
AU2020501A (en) | Chemotherapy treatment | |
AU4935000A (en) | Antibodies | |
AU3678100A (en) | Biosensor | |
AU5089400A (en) | Arthritis treatment | |
AU2728600A (en) | Integrated pyrolysis gasoline treatment process | |
AU5441000A (en) | Human monoclonal antibody | |
AU7123400A (en) | Method for reducing costs associated with inebriation | |
AU2452301A (en) | Protein methylarginine-specific antibodies | |
WO2000065468A8 (en) | Process optimation | |
HK1054024A1 (en) | Processes for producing tetrahydropyranyl-4-sulfonate and 4-aminotetrahydropyran compound. | |
AU7075200C1 (en) | Dosages for treatment with anti-ErbB2 antibodies | |
AU7788600A (en) | Colon-tumour-associated antigens | |
AU3812499A (en) | Stopper | |
AU4598100A (en) | Treating cancer | |
AU1547601A (en) | Modified browser system | |
AUPQ484699A0 (en) | Antibodies | |
AU2002301764A1 (en) | Treatment with anti-Erb2 antibodies | |
AUPQ118599A0 (en) | Combustion process | |
AUPP909299A0 (en) | Combustion process | |
GB9914057D0 (en) | Antibody therapy | |
GB0212763D0 (en) | Antibodies | |
GB9918051D0 (en) | Antibodies |